Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir and Telbivudine in Immune-tolerant CHB Awaiting Assisted Reproduction
NCT02338674Phase 2Completed
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Started Oct 2014; status: completed.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02338674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338674.